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Key points
 The carotid body is a peripheral arterial chemoreceptor that regulates ventilation in response
to both acute and sustained hypoxia.
 Type I cells in this organ respond to low oxygen both acutely by depolarization and dense core
vesicle secretion and, over the longer term, via cellular proliferation and enhanced ventilatory
responses.
 Using lineage analysis, the present study shows that the Type I cell lineage itself proliferates and
expands in response to sustained hypoxia.
 Inactivation of HIF-2α in Type I cells impairs the ventilatory, proliferative and cell intrinsic
(dense core vesicle) responses to hypoxia.
 Inactivation of PHD2 in Type I cells induces multilineage hyperplasia and ultrastructural
changes in dense core vesicles to form paraganglioma-like carotid bodies.
 These changes, similar to those observed in hypoxia, are dependent on HIF-2α.
 Taken together, these findings demonstrate a key role for the PHD2–HIF-2α couple in Type I
cells with respect to the oxygen sensing functions of the carotid body.
Abstract The carotid body is a peripheral chemoreceptor that plays a central role in mammalian
oxygen homeostasis. In response to sustained hypoxia, it manifests a rapid cellular proliferation
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and an associated increase in responsiveness to hypoxia. Understanding the cellular andmolecular
mechanisms underlying these processes is of interest both to specialized chemoreceptive functions
of that organ and, potentially, to the general physiology and pathophysiology of cellular hypo-
xia. We have combined cell lineage tracing technology and conditionally inactivated alleles in
recombinant mice to examine the role of components of the HIF hydroxylase pathway in specific
cell types within the carotid body. We show that exposure to sustained hypoxia (10% oxygen)
drives rapid expansion of the Type I, tyrosine hydroxylase expressing cell lineage, with little
transdifferentiation to (or from) that lineage. Inactivation of a specific HIF isoform, HIF-2α, in
the Type I cells was associated with a greatly reduced proliferation of Type I cells and hypoxic
ventilatory responses, with ultrastructural evidence of an abnormality in the action of hypoxia
on dense core secretory vesicles. We also show that inactivation of the principal HIF prolyl hydro-
xylase PHD2 within the Type I cell lineage is sufficient to cause multilineage expansion of the
carotid body, with characteristics resembling paragangliomas. Thesemorphological changes were
dependent on the integrity of HIF-2α. These findings implicate specific components of the HIF
hydroxylase pathway (PHD2 and HIF-2α) within Type I cells of the carotid body with respect to
the oxygen sensing and adaptive functions of that organ.
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Introduction
Acclimatization is an important physiological response
to low oxygen levels and the ventilatory component of
this response is mediated by the carotid body (CB), a
peripheral chemoreceptor (Bisgard, 2000; Robbins, 2007;
Kumar & Prabhakar, 2012; Lopez-Barneo et al. 2016).
Previous work has implicated the HIF system in the
modulation of CB function (Kline et al. 2002; Peng et al.
2011; Bishop et al. 2013). HIF is regulated by a series of
2-oxoglutarate-dependent dioxygenases that generate an
oxygen-dependent signal by the catalysis of hydroxylation
on specific prolyl residues in HIFα subunits (Bishop &
Ratcliffe, 2014). Mammalian cells express three closely
related HIF prolyl hydroxylases: PHD1, 2 and 3, of which
PHD2 is the most abundant and important regulator in
most cells. Similarly, HIFα is represented in mammalian
species by three isoforms: HIF-1α, HIF-2α and HIF-3α.
HIF-1α and HIF-2α are the most abundant and the best
studied. Despite many similarities in their structure and
regulation by the PHDs, increasing evidence indicates
that they have distinct transcriptional targets and physio-
logical roles (Schodel et al. 2011; Ratcliffe et al. 2017). In
recent work, we have observed that general inactivation
of HIF-2α, but not HIF-1α, ablates the proliferation that
occurs within days of exposure to hypoxia in adult mice
(Hodson et al. 2016).
Whilst this and other work has implicated the HIF
hydroxylase ‘oxygen sensing’ pathway in this response,
it leaves open the question of which cell or cells are
responsible for the effects, and whether and under what
circumstances activation of HIF in one or more specific
cell types is sufficient to drive proliferation and expansion
of the CB. These questions are important both for
understanding the physiological mechanisms by which
hypoxia signalling pathways impinge on CB physiology,
as well as for understanding the pathophysiology of
CB paraganglioma, a tumour that is more commonly
observed (10-fold) in individuals living at altitude
(Saldana et al. 1973). Because hypoxia pathways are
commonly activated in cancer (Ratcliffe, 2013; Kaelin,
2017), these questions may also be of general relevance
to that disease.
Although labelling of DNA synthesis with bromo-
deoxyuridine (BrdU) in cells that were identified as
Type I (based on morphological appearances and the
expression of an immunohistochemical marker) has
been interpreted as evidence for the cell-autonomous
proliferation of that population (Paciga et al. 1999; Nurse
& Fearon, 2002; Wang & Bisgard, 2002; Wang et al.
2008), other studies have suggested that such cells might
arise mainly by proliferation within a stem cell niche of
glia-like sustentacular cells followed by subsequent trans-
differentiation (Pardal et al. 2007).
To study this process further, we have applied
lineage tracing technology, together with cell-specific
inactivation of particular components of the HIF hydro-
xylase pathway. We report that exposure to 28 days
of hypoxia in the mouse promotes the proliferation
and expansion of lineage labelled Type I cells of
the CB. HIF-2α inactivation in the Type I cells of
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the CB severely reduced both hypoxia-induced CB
proliferation and ventilatory acclimatization to hypoxia.
Furthermore, inactivation of the principal HIF prolyl
hydroxylase PHD2 within Type I cells was sufficient
to drive the growth of greatly enlarged and highly
vascular CBs via mechanisms that are dependent on
HIF-2α.
Our findings provide insights into the action of hypoxia
on growth of the CB and suggest a model for the study of
hypoxia-associated paraganglioma.
Methods
Ethical approval and animals
Animal procedures were approved by the University
of Oxford Medical Sciences Division Ethical Review
Committee and were compliant with the UKHomeOffice
Animals (Scientific Procedures) Act 1986. The authors
understand the ethical principles of The Journal of Physio-
logy and all work was conducted in compliance with
stated standards (Grundy, 2015). Mice were housed in
individually ventilated cages and fed ad libitum on a
standard diet. Male mice aged 3 months old were used
for all comparisons with littermate matched controls,
except where stated otherwise. Phd2f/f, Hif-1αf/f and
Hif-2αf/f (where ‘f’ denotes the floxed allele) conditional
knockout have been described previously and were
obtained from these sources (Cramer et al. 2003; Gruber
et al. 2007; Mazzone et al. 2009). Mouse lines in
which tamoxifen regulated Cre recombinase is expressed
from the tyrosine hydroxylase (TH) (TH-IRES-CreER;
hereafter referred to asTHCreER) and glial fibrillary acidic
protein (GFAP) (GFAPCreERT2; hereafter referred to as
GFAPCreER) promoters have been described previously
(Hirrlinger et al. 2006; Rotolo et al. 2008). The Ai14
tdTomato reporter line has been described previously,
demonstrating robust fluorescence following activation
by Cre recombinase (Madisen et al. 2010). Each line
had been backcrossed with C57BL/6 for at least five
generations and was intercrossed to generate littermates
of appropriate genotypes. The mouse line with Cre
recombinase expressed fromtheTHpromoter via an inter-
nal ribosomal entry sequence (TH-IRES-Cre; hereafter
referred to as THCre) has been described previously,
demonstrating expression in catecholaminergic neuro-
nes. In this line, some recombination has been described
in germ cells, leading to constitutive recombination in
offspring (Lindeberg et al. 2004). Therefore, all mice used
for mating and experiments were screened for germline
recombination using ear biopsy samples and affected
animalswere eliminated from the study. PCRprimers used
to test for recombination are as described in Adam et al.
(2011).
Chronic hypoxic exposure of mice and drug
administration
Tamoxifen (prepared to 20mgmL−1 in corn oil containing
10%ethanol; Sigma, St Louis,MO,USA)was administered
by oral gavage to 6 week-old mice at a dose of 2 mg
per day for 5 consecutive days as described previously
(Arsenault et al. 2013; Hodson et al. 2016). After a 5
day tamoxifen ‘washout’ period (t = 0 days), littermate
micewere split into hypoxia andnormoxia control groups.
Mice were administered 50mg kg−1 BrdU via I.P. injection
immediately prior to exposure to hypoxia or normoxia,
followed by supplementation of drinking water with BrdU
(1mgmL−1 BrdU and 1% sucrose) for the duration of the
experiment. Hypoxic mice were placed into a normobaric
altitude chamber and acclimatized to decreasing oxygen
levels over 24 h, and then held at 10% oxygen for 7
or 28 days with controlled temperature, humidity and
carbon dioxide levels and free access to food and water.
Normoxic littermate controls were maintained under
normal housing conditions and supplemented with BrdU
water (1 mg mL−1 BrdU and 1% sucrose). All mice were
weighed at the start of the procedure and monitored
daily for general condition and changes in body weight.
No significant differences in body weight or surface
body temperature (assessed by thermal imaging using an
infrared camera, PI 160; Optris, Berlin, Germany) were
noted in Hif-2αf/f;THCreER mice vs. Hif-2αf/f littermate
controls during the hypoxic exposure.
Plethysmography
Tidal volume and respiratory rate were measured in
awake, unrestrained mice using individual whole body
plethysmographs (600 mL volume; Model PLY4211;
Buxco, DSI, St Paul,MI, USA) (Bishop et al. 2013; Hodson
et al. 2016). Minute ventilation was calculated from
tidal volume and respiratory rate. Ventilatory parameters
were derived using FinePointe software (Buxco) and
adjusted to body weight as measured immediately prior
to plethysmography. Premixed gas was delivered to each
chamber as described previously (Bishop et al. 2013;
Hodson et al. 2016). The acute hypoxic stimuli consisted
of 10% oxygen, balance nitrogen or 10% oxygen, 3%
carbon dioxide, balance nitrogen. The hypoxic ventilatory
response (HVR) to each stimulus was defined as the
difference between minute ventilation during the 1 min
prior to the onset of hypoxia and the first 1 min of
stable hypoxia (Bishop et al. 2013; Hodson et al. 2016).
Ventilatory instabilities (such as apnoeas and periodic
breathing) were noted in the immediate post-hypoxic
period, as reported previously for mice on a C57BL/6
genetic background (Han et al. 2001, 2002). However, no
differences in the frequency of these events were noted
between the genotypes tested.
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
4396 J. W. Fielding and others J Physiol 596.18
Blood measurements
Blood was taken from the inferior vena cava of mice using
heparinized capillary tubes after terminal anaesthesia,
and haematocrits were measured using a haematocrit
centrifuge (model C-MH30; Unico, Dayton, NJ, USA).
Tissue preparation
Mice were killed by overdose of isoflurane and
exsanguination when still in their experimental oxygen
condition (i.e. hypoxic mice were culled in the
altitude chamber). This was followed by immediate
perfusion fixation and dissection of tissues that were
then immersed in 4% paraformaldehyde/PBS overnight.
Tissues were then transferred to 30% sucrose/PBS or 70%
ethanol prior to processing and embedding. Tissues for
immunofluorescence were embedded in OCT embedding
compound and cryosectioned to an 8 μm thickness
using a CM-3050-S Cryostat (Leica Biosystems, Wetzlar,
Germany). Paraffin-embedded tissues were sectioned to
a 4 μm thickness using an RM2135 microtome (Leica
Biosystems).
Immunohistochemistry and in situ hybridization
Cryosections were immunostained with rabbit anti-TH
antibody (dilution 1:500; NB300-109; Novus Biologicals,
Cambridge, UK), rabbit anti-GFAP (dilution 1:500;
ZO334; Dako, Ely, UK), rat anti-endomucin (dilution
1:500; sc-65495; Santa Cruz Biotechnology, Santa Cruz,
CA, USA) and sheep anti-BrdU (dilution 1:500; ab1893;
Abcam, Cambridge, UK), followed by detection with
an Alexafluor 488 goat anti-rabbit (dilution 1:500;
#R37116; Thermo Fisher Scientific, Loughborough, UK)
or an Alexafluor 488 goat anti-rat (1:500; A11006;
Thermo Fisher Scientific) secondary antibody and
a 4′,6-diamidino-2-phenylindole nuclear counterstain
(dilution 1:2000; ab104139; Abcam). Paraffin-embedded
tissues were immunostained with anti-TH (dilution
1:5000; NB300-109; Novus Biologicals) or with an
anti-BrdUantibody in accordancewith themanufacturer’s
instructions (dilution 1:10; #551321; Becton Dickinson
Biosciences, Oxford, UK) as described previously (Bishop
et al. 2013; Hodson et al. 2016).
Hif-1α, Hif-2α and Vegfa transcripts were detected via
in situ hybridization on sections from paraffin-embedded
tissues using the RNAscope manual assay in accordance
with the manufacturer’s instructions (Advanced Cell
Diagnostics, Newark, CA, USA). Loss of Hif-2α
expression in mice with conditional gene inactivation
was demonstrated using the BaseScope kit (Advanced
Cell Diagnostics) and a customized probe targeted to
exon 2 (Advanced Cell Diagnostics), which is flanked
in the Hif-2α floxed allele by LoxP sites and hence
absent in any transcripts from cells where Cre mediated
recombination has taken place (Gruber et al. 2007). To
obtain dual in situ hybridization/immunohistochemically
stained images, the RNAscope protocol was performed
first followed by immunostaining with anti-TH or
anti-BrdU antibodies as described above. The percentage
of TH+ cells expressing Hif-2α mRNA was quantified
to give a measure of the efficiency of tamoxifen-induced
recombination in Type I cells throughout the CB.
Sampleswere imagedusing amodel 710 confocalmicro-
scope or a DM 1000 LED microscope (Leica Biosystems).
Stereological estimation of cell number, cell density and
CB volume was performed using ImageJ (NIH, Bethesda,
MD, USA) on alternate cryosections or on every fourth
paraffin section as describedpreviously (Bishop et al. 2008;
Bishop et al. 2013; Hodson et al. 2016).
Electron microscopy
The bifurcation of the carotid artery, containing the
CB, was removed and immediately placed in 4%
glutaraldehyde in 0.1 M phosphate buffer and processed
for routine electron microscopy. The tissue was post-fixed
in osmium tetroxide, treated en bloc with uranyl acetate,
dehydrated in ethanol and then treated with propylene
oxide and embedding epoxy resin. Sections (1 μm) were
cut from the blocks and examined by light microscopy to
identify the location of theCBwithin the bifurcation. Thin
sections of selected areas were stained with uranyl acetate
and lead citrate prior to examination with a transmission
electronmicroscope (JEOL 1200EX; JEOL, Tokyo, Japan).
The approximate area of Type I cells was calculated from
electron micrographs of centrally sectioned cells using
ImageJ.
Statistical analysis
Data are shown as the mean ± SEM. Statistical analyses
were performed using unpaired Student’s t tests. For
repeated measures, data were analysed by ANOVA
followed by Tukey’s multiple comparison test or t test
with Holm–Sidak correction for multiple comparisons
as appropriate and as described in Hodson et al. (2016).
P < 0.05 was considered statistically significant.
Results
The effect of hypoxia on Type I and II lineage labelled
cell populations in the CB
To assess which populations of cells in the CB proliferate
in response to hypoxia, specific cell types were labelled
in normoxic animals using an inactive Ai14 tdTomato
reporter gene (Madisen et al. 2010). This gene was
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recombined into the ubiquitously expressed Rosa26
locus and then activated in specific lineages by cell
type specific expression of Cre recombinase, allowing
the marking of cells and tracing of their progeny by
tdTomato fluorescence. Inducible Cre recombinase trans-
geneswere selected topermit timedcell-specific expression
following exposure to tamoxifen: a TH promoter trans-
gene (THCreER) whose expression is restricted within the
CB to Type I (glomus) cells (Rotolo et al. 2008; Macias
et al. 2014) and aGFAPpromoted transgene (GFAPCreER)
whose expression is restricted to glia-like support cells
(Hirrlinger et al. 2006), such as the Type II cells of the CB
(Kameda, 2005).
For each transgene, we aimed to activate the reporter
gene by administration of tamoxifen for 5 days. This
was followed by a 5 day ‘washout’ period to allow
clearance of the drug, before animals were exposed to
an atmosphere of 10% oxygen for 28 days. Thus the
expansion, or otherwise, of the marked populations and
their progeny could be analysed and compared with
control animals maintained in normoxia. A number
of control experiments were performed to ensure the
integrity of the lineage marking strategy. First, we
confirmed tamoxifen-restricted activation of the lineage
markers: tdTomato expression was not detectable in
tdTomatof/+;THCreER non-tamoxifen-treated animals.
Because the TH gene has been reported to be induced
by hypoxia (Czyzyk-Krzeska et al. 1992), we also
examined the effect of the 28 day hypoxic exposure
on tdTomatof/+;THCreER animals that had not received
tamoxifen (Fig. 1A, far left). Again, no fluorescent cells
were detected, indicating that recombinant activation of
the lineage markers was tightly restricted by tamoxifen
under the conditions of our experiments. Second, we
confirmed the anticipated lineage specificity of the lineage
marker activation prior to hypoxic exposure. These
experiments were performed in animals treated with
tamoxifen for 5 days and then allowed to ‘washout’ for
5 days [i.e. at a time equivalent to the beginning (t = 0) of
the hypoxic exposure]. This enabled exact comparison of
any alteration in the morphology or associated immuno-
reactivity after 28 days of hypoxia with the position prior
to that exposure (Fig. 1A).
At t = 0, tdTomatof/+;THCreER animals manifest large
numbers of tdTomato positive (tdTomato+) Type I cells,
as defined by typical morphological appearances (i.e.
large cells with rounded nuclei arranged in a glomerular
architecture), confirming the anticipated location of the
lineage marker (Fig. 1A, middle left). To further confirm
this and to estimate recombination efficiency, sections
of CBs were immunostained with an anti-TH anti-
body (Fig. 1A, middle left). Confocal microscopy was
used to assess colocalization of TH immunoreactivity
and tdTomato: morphologically; by the use of Z-stack
planar analyses; and by the appearance of a perinuclear
halo of yellow, derived from co-incidence of nuclear
tdTomato and cytoplasmic greenfluorescence signals from
anti-TH (Fig. 1A, middle left). Twenty images from each
of three pairs of CBs were analysed, indicating that
tdTomato fluorescence was essentially confined (>99%)
to TH positive (TH+) Type I cells (Fig. 1A, middle left).
Conversely,80%of TH+ cells were tdTomato+ (Fig. 1A),
indicating a high efficiency of recombination. Similarly,
and as expected at t = 0, tdTomatof/+;GFAPCreER
animals manifest tdTomato fluorescence in Type II cells,
as defined by irregular morphology, small nuclear size
and colocalization with anti-GFAP immunoreactivity
(Fig. 1B, far left) (De Kock, 1951; Kameda, 2005).
Fewer tdTomato+ cells were observed than in THCreER
animals (Fig. 1A, B and D), consistent with the pre-
viously described ratios of Type II vs. Type I cells in
the CB (Kumar & Prabhakar, 2012). Confocal imaging,
performed as above at t = 0, demonstrated that 50%
of GFAP+ cells were tdTomato+, indicating a substantial,
though lower, recombination frequency (Fig. 1B, far left).
These experiments therefore confirmed accurate lineage
marking of CB cells, demonstrated that activation of the
marker was tightly restricted to the 5 day exposure of
animals to tamoxifen, and confirmed lineage restriction of
the marker after tamoxifen ‘washout’ immediately prior
to the 28 day experimental exposure to hypoxia.
To define the response of lineage marked Type I
cells, tdTomatof/+;THCreER animals were exposed to 10%
oxygen for 28 days or maintained in normoxia. This
28 day time point was selected as a time point that has
been consistently demonstrated to result in significant
hypoxia-induced hyperplasia of the CB in rodent models
(Laidler & Kay, 1975; Dhillon et al. 1984; McGregor
et al. 1984). To identify proliferating cells, BrdU was
administered via I.P. injection at t = 0 and added at
1 mg mL−1 to the drinking water for the duration
of the experiment. As expected, hypoxia led to a sub-
stantial 3.5-fold increase in CB size in hypoxic animals
(0.0068± 0.0005mm3 vs. 0.0019± 0.0004mm3 in control
animals, P < 0.0001). Analysis of these CBs revealed
a commensurate 3-fold increase in the number of cells
expressing tdTomatofluorescence (2457±152 vs. 745±50
cells per CB, P < 0.0001) (Fig. 1D, upper). Morphometric
analyses of the CBs of hypoxic animals, using confocal
microscopyandanti-THimmunohistochemistry, revealed
that essentially all (>99%) of this expanded number
of tdTomato+ fluorescent cells manifested Type I cell
morphology and/or co-labelled with anti-TH as had been
observed in the t = 0 analyses, and as was also observed
in CBs from control animals maintained in parallel in air
(Fig. 1A, right). Additional analyses indicated that, in each
setting (t = 0, normoxia and hypoxia), the proportion of
TH+ cells that were tdTomato+ was constant at 80%
(Fig. 1A). These observations suggest that there was little
differentiation to or from the expanding Type I cell
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Figure 1. The effect of chronic hypoxia on lineage labelled Type I and Type II cells in the CB
Representative images and morphometric analyses of lineage labelled tdTomatof/+;THCreER mice (A, C and D)
and tdTomatof/+;GFAPCreER mice (B and D). A, characterization of tdTomato expression (tdT, red) and TH (green)
immunostaining; far left: non-tamoxifen (TMX) treated mice exposed to hypoxia (28 days at 10% oxygen); middle
to far right: analysis immediately after tamoxifen ‘washout’ (t = 0), and normoxic or hypoxic mice after a further
28 days (t = 28); morphometric analyses on each are presented below. B, characterization of tdTomato (red) with
GFAP (green) or TH (green) immunostaining immediately after tamoxifen ‘washout’ (t = 0); morphometric analyses
on each are presented below. C, proliferation in hypoxic Type I cells; colocalization of BrdU+ immunostaining and
tdTomato fluorescence (purple cells, marked with white arrowheads) in hypoxic tdTomatof/+;THCreER mice. Far
right: electron microscopy image of a Type I cell (confirmed via the presence of DCVs; see insert) undergoing
mitosis from a mouse exposed to 7 days of hypoxia. Scale bars = 1 μm (low power) and 100 nm (high power).
D, representative images and quantification of tdTomato fluorescence in the CBs (CB edge outlined in white) of
hypoxic mice (28 days at 10% oxygen) vs. normoxic controls (28 days normoxia) in tdTomatof/+;THCreERmice and
tdTomatof/+;GFAPCreER mice. Values shown are the mean ± SEM. ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001.
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population in hypoxic animals. Further analysis using
anti-BrdUrevealedBrdU incorporation inmany, although
not all, of the tdTomato+ cells (Fig. 1C, left). Although
quantitative assessment of the proportion of double
(BrdU+/tdTomato+) labelled cells is difficult, definite
co-labelling was observed in the region of one-third of the
BrdU+ cells. Consistent with this, ultrastructural analyses
identified dense core vesicle containing Type I cells under-
going mitosis (Fig. 1C, right). In addition, we observed
BrdU labelling in cells that were not tdTomato+ and vice
versa. Taken together, these findings indicate that the Type
I cell lineage expansion in hypoxia is substantially derived
from the Type I cells that are present in the normoxic CB,
and that this is driven by the proliferation of at least a
proportion of such cells.
To define the response of lineage marked Type II cells,
tamoxifen-treated tdTomatof/+;GFAPCreER mice were
similarly given BrdU and exposed to hypoxia for 28 days,
or maintained in air after which CBs were examined using
tdTomato fluorescence and immunostaining for BrdU and
GFAP. These analyses revealed that this population also
proliferated and expanded within the hypoxic CBs, but to
a lesser extent than the Type I lineage marked population:
258 ± 33 vs. 145 ± 10 tdTomato+ cells per CB being
observed in hypoxic animals vs. those maintained in air
(Fig. 1D, lower). In keeping with the smaller expansion
in cell number vs. that of the Type I lineage marked
population, the density of these cells appeared reduced
in the enlarged hypoxic CBs (274 ± 22 vs. 475 ± 39
tdTomato+ cells mm−2, P = 0.0005) (Fig. 1D, lower).
Morphological examination and immunostaining with
anti-TH did not identify substantial transdifferentiation
into Type I cells in either t = 0 or after 28 days of hypoxia
or normoxia (Fig. 1B and data not shown).
Cell-specific expression and inactivation of HIF-α
isoforms
The above findings demonstrate robust proliferation of
Type I cells of the CB in response to hypoxic challenge.
However, because hypoxia occurs across all cells of the
organ, it was not possible to determine whether this
is a cell-autonomous response. In previous work, we
demonstrated that general inactivation of HIF-2α, but
not HIF-1α, in adult animals ablates the proliferation
of cells within the CB that is otherwise observed during
a 7 day exposure to 10% oxygen (Hodson et al. 2016).
The importance of HIF-2α, as demonstrated by these
experiments, is consistent with recent reports of high
levels ofHif-2α mRNA in the whole CB (Zhou et al. 2016;
Gao et al. 2017) and in isolated Type I cells (Zhou et al.
2016). To confirm these reports and extend them to a
cellular level within the intact CB, we performed in situ
hybridization for Hif-1α and Hif-2α mRNA within the
CB and surrounding tissues. These experiments revealed a
modest signal for Hif-1α mRNA that was uniform across
the tissues in contrast to a strong Hif-2α mRNA signal
that was tightly circumscribed within the CB (and mostly
absent in neighbouring TH+ superior cervical ganglion
and nerve fibres) and appeared to be particularly dense
in clusters of cells morphologically typical of Type I cells
(Fig. 2A). This was confirmed by dual detection of TH
immunoreactivity (Fig. 2B, left).
We therefore hypothesized that HIF-2α activation
by hypoxia within the CB Type I cells might drive
the proliferation of that population. To test this
hypothesis, we intercrossed THCreER with Hif-2αf/f
animals (Hif-2αf/f;THCreER) and administered tamoxifen
for 5 days to inactivate HIF-2α in the Type I cells of
CBs of adult animals. As found previously, a 5 day
period of tamoxifen ‘washout’ was applied before mice
were dosed with BrdU and exposed to sustained hypo-
xia (10% oxygen for 7 days) or maintained in air.
Alterations in CB function were assessed at this time,
using plethysmography to measure responsiveness to a
short (5 min) hypoxic challenge, performed immediately
after removal from sustained hypoxia; CB morphological
changes were assessed by light and electron microscopy.
The hypoxic responses of animals of each of the inter-
crossed genotypes were compared with those in controls
that had been similarly exposed to tamoxifen but which
only bore the Hif-2αf/f alleles and therefore could not
recombine. As before, BrdU incorporation was assessed
using an anti-BrdU antibody. The results are shown in
Fig. 2C and reveal a marked, but incomplete, reduction
in BrdU incorporation (1743 ± 162 vs. 2993 ± 153
BrdU+ cells mm−2 in Hif-2αf/f;THCreER vs. Hif-2αf/f,
P = 0.0006). Dual immunohistochemical labelling and
in situ hybridization showed that cells expressing Hif-2α
mRNA, which colocalized with TH-immunoreactivity,
were much reduced (by 50%) in Hif-2αf/f;THCreER
animals, consistent with cell type specific inactivation
of HIF-2α (Fig. 2B, middle). However, regions of
Hif-2α signal remained (Fig. 2B, middle) and appeared
to be associated with BrdU positive cells (Fig. 2B,
right), suggesting that the more moderate reduction
in cell proliferation in these animals, vs. the pre-
viously reported effect of general inactivation of HIF-2α
(Hodson et al. 2016), is a result at least in part of
incomplete recombination. To test whether this reduction
in proliferation leads to a reduction in Type I cell
number/CB size, we assessed the effects of 28 days of hypo-
xia on CBs from HIF-2 α inactivated mice to facilitate
comparisons with the lineage tracing experiments
performed in Fig. 1D. This shows a large reduction in
labelled Type I cells (Fig. 2D), as well as CB volume
(0.0022±0.0003mm3 vs. 0.0068±0.0003mm3 inhypoxic
Hif-2αf/f;tdTomatof/+;THCreER vs. tdTomatof/+;THCreER
controls, P < 0.0001), that significantly impairs the
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Figure 2. Hif-2α mRNA expression in the CB and the effect of HIF-2α inactivation on CB proliferation
A, in situ hybridization for Hif-1α and Hif-2α mRNA in CBs from normoxic wild-type (WT) mice. Low power image
showing Hif-2α expression (pink) around the carotid bifurcation, including the CB and superior cervical ganglion
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(SCG) (left). High power images of CB tissue showing Hif-1α (middle) and Hif-2α (right) expression (brown). B and
C, representative images of CBs from Hif-2αf/f;THCreER, Hif-2αf/f;GFAPCreER and Hif-2αf/f littermate control mice
after exposure to 10% oxygen for 7 days. B, dual in situ hybridization and immunostaining for Hif-2α mRNA (pink)
and TH (brown) or BrdU (brown). C, immunostaining for BrdU (brown), morphometric analyses are presented
below. Values shown are the mean ± SEM; n = 4–11. D, representative images and quantification of tdTomato+
cell numbers in the CBs (CB edge outlined in white) of hypoxic (28 days at 10% oxygen) tdTomatof/+;THCreER
vs. Hif-2αf/f;tdTomatof/+;THCreER mice; n = 4. Values shown are the mean ± SEM. ∗∗P < 0.01. E, endomucin
(green) and BrdU (red) immunostaining (cells with colocalization are marked with white arrowheads) in mice. Left:
tdTomatof/+;THCreERmice exposed to hypoxia (28 days at 10% oxygen) with orthogonal view of Z stacks showing
colocalization; middle and right: images from Hif-2αf/f;THCreER and Hif-2αf/f littermate controls exposed to 7 days
of chronic hypoxia.
hypoxic expansion observed in Fig. 1D. Overall, these
findings suggest that the rapid proliferation and expansion
of Type I cells in CBs of adult hypoxic mice is at least
partially a cell-autonomous/autocrine response that is
dependent on HIF-2α.
Our previous lineage tracing experiment indicated
that many BrdU+ proliferating cells did not co-label
with tdTomato in either THCreER or GFAPCreER mice.
These analyses revealed that many of these cells had
appearances of endothelial cells and appeared to cluster
around the CB vasculature. To confirm the endothelial
origin of substantial numbers of these dividing cells, we
used double immunohistochemical labelling of anti-BrdU
and anti-endomucin on hypoxic mice. This demonstrated
that 40% of the total BrdU+ cells in the proliferating
CB co-labelled with endomucin (Fig. 2E, left, white
arrowheads). Furthermore, tdTomato did not colocalize
with endomucin in CBs from tdTomatof/+;THCreERmice,
indicating that these proliferating endothelial cells were
not derived from lineage labelled Type I cells. To assess
whether the proliferation of this population of cells is also
affected by the loss of HIF-2α in Type I cells, we assessed
the colocalization of BrdU and endomucin in CBs from
hypoxicHif-2αf/f;THCreERmice and controls. The density
of BrdU+/endomucin+ cells was significantly reduced in
Hif-2αf/f;THCreERmice relative to controls (762± 114 vs.
1256± 101 BrdU+/endomucin+ cells mm−2, P = 0.0174)
(Fig. 2E). This suggests that hypoxia-induced endothelial
cell proliferation is at least partially driven by HIF-2α
activation in the Type I cells, possibly via paracrine effects.
Functional comparisons of the same animals
(Hif-2αf/f;THCreER vs. Hif-2αf/f) revealed marked
differences: the enhanced HVR, which was observed after
7 days of hypoxia in Hif-2αf/f (control, unrecombined)
animals, was much reduced inHif-2αf/f;THCreER animals
(HVR of 9.13 ± 0.78 vs. 5.99 ± 0.42 mL min−1 g−1,
P= 0.003) (Fig. 3A andTable 1). This impaired ventilatory
acclimatization to hypoxia was accompanied by a more
severe polycythaemic response inHif-2αf/f;THCreERmice
compared to Hif-2αf/f controls (65.8 ± 0.4% vs.
61.2 ± 1.1% haematocrit, P = 0.002) (Fig. 3A), consistent
with an impact on systemic oxygen delivery.
Some reduction in HVR in Hif-2αf/f;THCreERmice
was detectable even prior to chronic hypoxic exposure,
although this did not reach statistical significance (Fig. 3A
and Table 1). Reduced ventilatory responses under base-
line conditionshavebeennotedpreviously inothermodels
of genetic inactivation of HIF-2α: inducible, ubiquitous
inactivation of HIF-2α significantly reduced HVRs prior
to chronic hypoxia and a similar, non-significant trend
was observed in Hif-2α+/− mice (Hodson et al. 2016).
Taken together, this suggests a role for HIF-2α in the acute
hypoxic ventilatory response, with the varying levels of
residual HVR following inactivation of HIF-2α perhaps
reflecting the degree to which there is residual Hif-2α
mRNA/incomplete recombination.
Similar experiments performed on Hif-2αf/f;
GFAPCreER vs. Hif-2αf/f animals revealed no differences
in either the BrdU labelling, hypoxic ventilatory responses
or haematocrit (Figs 2C and 3B and Table 1). Although
these experiments do not support a major role for HIF-2α
within Type II cells in the overall response of the carotid
to hypoxia, lower levels of Hif-2α mRNA in these cells
(Fig. 2B) and a lower efficiency of recombination, as
assessed by the tdTomato reporter gene experiments
described above (Fig. 1B), make it difficult to draw a firm
negative conclusion.
However, given that both functional changes and
proliferative responses to 7 days of chronic hypoxia within
the Type I cells of the CB appeared to be dependent on
the high levels of HIF-2α in these cells, we next aimed
to determine whether inactivation of HIF-2α affected
the integrity of Type I cells as well as their number.
Accordingly, we compared the ultrastructural appearances
of the Type I cells in Hif-2αf/f and Hif-2αf/f;THCreER
animals after 7 days of hypoxia or maintenance in
normoxia (Fig. 4). In animals maintained in normoxia,
as anticipated, Type I cells contained large numbers of
dense core vesicles (DCVs) aligned close to the plasma
membrane (Fig. 4). In animals exposed to hypoxia,
marked changes in these vesicles were observed, including
a reduction in DCV density in hypoxic vs. normoxic
Hif-2αf/f controls (1.37 ± 0.14 vs. 7.20 ± 0.25 DCVs
μm−2, P < 0.0001) and the appearance of large ‘eccentric’
DCVs with a lucent ‘halo’ around the dense core (Fig. 4,
lower, insert). Strikingly, in many Type I cells from
Hif-2αf/f;THCreER mice, these hypoxia-induced changes
in dense core vesicles were almost completely absent
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(4.45 ± 0.94 vs. 1.37 ± 0.14 DCVs μm−2 in hypo-
xic Hif-2αf/f;THCreER vs. Hif-2αf/f mice, P = 0.0121)
(Fig. 4). Consistent with incomplete recombination, the
alterations in hypoxia-induced ultrastructural changes
were cell-specific within the fields examined, with some
cells retaining the usual hypoxia-induced changes in dense
core vesicle appearance (Fig. 4, right). These findings
suggest that, within hypoxic Type I cells, HIF-2α is
required for both proliferation and for oxygen-dependent
vesicular functions, and that both changes might
contribute to the enhanced hypoxic ventilatory responses
observed after sustained hypoxia.
Further to these intracellular changes in dense core
vesicles, Type I cells were noted on electron micrographs
to undergo hypertrophy in response to hypoxia, with an
increase inType I cell size (mean cross sectional area 41± 4
vs. 64 ± 2 μm2 in normoxic vs. hypoxic Hif-2αf/f mice,
P < 0.01), as reported previously (Dhillon et al. 1984;
Pequignot et al. 1984; Mills & Nurse, 1993). This hyper-
trophy was not observed following inactivation of HIF-2α
in Type I cells (64 ± 2 vs. 44 ± 4 μm2 in hypoxicHif-2αf/f
vs. Hif-2αf/f;THCreER mice, P < 0.01).
Inactivation of the HIF prolyl hydroxylase PHD2 in
Type I cells of the CB
In animal cells, the levels of HIF-α proteins, and hence
the activity of HIF, is regulated by the oxygen-dependent
activity of the HIF prolyl hydroxylases: PHD1, PHD2 and
PHD3 (Epstein et al. 2001; Berra et al. 2003; Appelhoff
et al. 2004). Previous work from our laboratory identified
PHD2 as the most important of these enzymes in
regulating ventilatory sensitivity to hypoxia, CB volume
and Type I cell number (Bishop et al. 2013; Hodson et al.
2016). These experiments used both constitutive hemi-
zygousPhd2+/− animals (Bishop et al. 2013) and inducible
general inactivation of PHD2 in adult animals (Hodson
et al. 2016), although they did not address which cell type
was responsible for the effects. Taken the findings reported
above into consideration, this led us to investigate the
possibility that inactivationofPHD2within theType I cells
of the CB alone would be sufficient to drive enlargement
of the CB. In these experiments, we used intercrosses
between animals bearing a constitutively active, but Type I
cell restricted, THCre recombinase transgene and animals
bearing a homofloxed Phd2 allele (Phd2f/f;THCre).
Figure 3. The effect of conditional HIF-2α inactivation upon ventilatory responses and haematocrit
levels in mice acclimatizing to chronic hypoxia
A, minute ventilation before, during and after an acute hypoxic stimulus (10% oxygen with 3% carbon
dioxide – white bars) and haematocrit measures of blood samples taken from Hif-2αf/f;THCreER and Hif-2αf/f
littermate controls. Measurements made before (0 days of hypoxia) and after (7 days of hypoxia) acclimatization
to 10% oxygen for 7 days. B, similar measurements from Hif-2αf/f;GFAPCreERmice and littermate controls. Values
shown are the mean ± SEM; n = 5–12. ∗∗P < 0.01.
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Table 1. Acute hypoxic ventilatory responses of mice after conditional inactivation of HIF-2α in TH or GFAP expressing cells before
and after chronic hypoxia exposure
Acute hypoxic stimulus Chronic hypoxia
duration
Hypoxic ventilatory response (mL min−1 g−1) ANOVA
Hif-2αf/f Hif-2αf/f;THCreER t test P value P value
10% O2 0 h –0.05 ± 0.30 0.03 ± 0.34 0.858
48 h 2.86 ± 0.33 1.70 ± 0.34 0.028 <0.0001
7 days 4.24 ± 0.21 2.84 ± 0.45 0.013
ANOVA P value 0.0069 0.069
10% O2/3% CO2 0 h 3.32 ± 0.28 2.89 ± 0.30 0.314
48 h 6.43 ± 0.56 4.58 ± 0.46 0.023 <0.0001
7 days 9.13 ± 0.78 5.99 ± 0.42 0.003
ANOVA P value <0.0001 0.012
Acute hypoxic stimulus Chronic hypoxia
duration
Hypoxic ventilatory response (mL min−1 g−1) ANOVA
Hif-2αf/f Hif-2αf/f;GFAPCreER t test P value P value
10% O2 0 h –0.24 ± 0.40 0.82 ± 0.57 0.167
48 h 1.30 ± 1.12 1.79 ± 0.85 0.804 0.0004
7 days 3.70 ± 0.87 3.06 ± 0.42 0.530
ANOVA P value 0.631 0.405
10% O2/3% CO2 0 h 3.15 ± 0.36 3.06 ± 0.31 0.844
48 h 6.66 ± 1.17 6.64 ± 0.49 0.987 <0.0001
7 days 8.25 ± 1.02 7.51 ± 0.73 0.571
ANOVA P value 0.647 0.873
Hypoxic ventilatory responses of Hif-2αf/f;THCreER and Hif-2αf/f;GFAPCreER mice vs. Hif-2αf/f littermate controls. Measurements were
taken after tamoxifen-induced recombination and before (0 h) and after (48 h, 7 days) exposure to 10% oxygen. Values shown are
mean ± SEM changes in minute ventilation in response to the indicated acute hypoxic stimulus; n = 5–12 littermate pairs for each
genotypic comparison. Significance was tested using two-way ANOVAs (right hand column P value = chronic hypoxia factor; bottom
row P value = genotype factor; right column, bottom row P value = chronic hypoxia/genotype interaction factor), followed by t tests
(with Holm–Sidak correction) for analysis of individual time points; P < 0.05 highlighted in bold.
When examined at 3months of age, thesePhd2f/f;THCre
animals manifest slightly, but not significantly, increased
baseline ventilation and hypoxic ventilatory responses
compared to control (Phd2f/f) animals (Fig. 5A and
Table 2). By contrast, morphological changes in CBs were
very striking (Fig. 5B and C). The organs were greatly
enlarged with multilineage hyperplasia involving large
numbers of Type I cells embedded in organs that also
manifested a large expansion of the vasculature (Fig. 5C,
upper). Electronmicroscopy showed that Type I cells were
surrounded by an expanded population of Type II cells
in a glomerular arrangement; in addition to this hyper-
plasia, Type I (but not Type II) cells increased in cell size
(Fig. 5B) similar to, but greater than, that observed in
hypoxia. Using light microscopy, a ‘clear cell’ phenotype
was observed in approximately half of the hyperplastic
CBs (Fig. 5C, lower), similar to the vacuolated cyto-
plasm observed in carotid paragangliomas (Ashley &
Evans, 1966; Robertson & Cooney, 1980; Wieneke &
Smith, 2009) and enlargedCBs fromhigh altitude dwellers
(Edwards et al. 1971; Edwards et al. 1972; Arias-Stella &
Valcarcel, 1976). Cellular ‘clearing’ was manifest as large
clear regions in Type I cells staining for neither lipid, nor
glycogen. Electron microscopic analyses revealed that a
large proportion of the Type I cells from Phd2f/f;THCre
mice contained a relatively low density of dense core
vesicles relative to controls (0.79 ± 0.09 vs. 8.82 ± 1.09
DCVs μm−2, P = 0.0018) but with increased vesicle
diameter. In addition, a number of the Type I cells
contained groups of larger eccentric vesicles (200–500 nm
in diameter) with an eccentrically displaced dense core
(Fig. 5D). In these granules, the cores also appeared
larger (150 nm vs. 90 nm in diameter) and more electron
dense. Taken together, the reduced DCV number and
appearance of eccentric DCVs was strongly reminiscent
of the changes observed under electron microscopy in
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Type I cells exposed to chronic hypoxia (Fig. 4, middle
right). The accumulation of large DCVs suggests that
the clearing described above may represent the fusion of
enlarged eccentric dense core vesicles, as reported pre-
viously in Type I cells obtained fromguinea pigs at altitude
(Edwards et al. 1972) and rats exposed to chronic hypoxia
(Laidler & Kay, 1978).
These experiments indicate that inactivation of PHD2
within the Type I cells of the CB is sufficient to drive
the generation of greatly enlarged CBs similar to, but
greater than, the enlargement observed following chronic
hypoxia (Fig. 5B vs. Fig. 1D). These morphological
alterations clearly involved cells other than the Type
I cells; in particular, the vasculature appeared to be
greatly expanded (Fig. 5C, upper). To confirm this,
and to investigate potential mechanisms, we performed
immunohistochemistry for the endothelial marker end-
omucin and in situ hybridization for vascular end-
othelial growth factor (Vegfa) mRNA (Fig. 6). These
experiments confirmed the existence of a grossly hyper-
plastic endomucin+ vasculature (Fig. 6A) and revealed
a high level of expression of Vegfa mRNA, which was
tightly confined to the CB and localized to Type I cells
(Fig. 6B), as identified by dual immunohistochemistry for
7 day Hypoxia
Hif-2af/f Hif-2af/f;THCreER Hif-2af/f Hif-2af/f;THCreER
7 day Normoxia
Figure 4. The effect of chronic hypoxia and HIF-2α inactivation upon Type I cell ultrastructure
Electron microscopy imaging of Type I cells from CBs of Hif-2αf/f;THCreER mice and Hif-2αf/f littermate controls
exposed to 7 days of 10% oxygen (n = 7) or normoxia (n = 3). Upper: low power electron microscope images
showing the general appearance of Type I cells. Middle: intermediate magnification showing the presence of large
numbers of DCVs in the Type I cells of both normoxia samples (left) and in the hypoxic Hif-2αf/f;THCreER mice (far
right) in contrast to the few DCVs present in the hypoxic Hif-2αf/f littermate control (middle right). Lower: high
magnification showing typical DCVs (black arrowheads) and eccentric DCVs (marked with white arrowheads).
Note the increased proportion of eccentric to normal DCVs in the hypoxic Hif-2αf/f (middle right) but not hypoxic
Hif-2αf/f;THCreER mice (far right). Representative and eccentric DCVs shown in inserts. Scale bars = 1 μm (upper
and middle) and 100 nm (lower and inserts).
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TH (Fig. 6C). Taken together, these findings suggest that
activation of hypoxia signalling in Type I cells by reduced
activity of PHD2 drives multilineage expansion within the
CB by both cell-autonomous or autocrine effects, as well
as paracrine effects.
Finally, given the importance of HIF-2α in mediating
CB responses to hypoxia in the adult, we aimed
to determine whether these effects of long-term
PHD2 inactivation were mediated by either or both
HIF-α isoforms. Accordingly, Phd2f/f;Hif-1αf/f;THCre and
Phd2f/f;Hif-2αf/f;THCre intercrosses were bred to generate
animals with combined inactivation of PHD2 andHIF-1α
or HIF-2α. As before, animals were examined at 3 months
of age. The hypoxic ventilatory responses in animals
with combined inactivation of PHD2 and HIF-1α were
similar to those observed with PHD2 inactivation alone
(4.07 ± 0.50 vs. 5.17 ± 0.51 mL min−1 g−1) (Fig. 7A
and Table 2). By contrast, this HVR was markedly
absent from Phd2f/f;Hif-2αf/f;THCre mice (0.30 ± 0.62 vs.
5.17± 0.51mLmin−1 g−1, P< 0.01) (Fig. 7A and Table 2)
and these mice were intolerant of acute exposure to 10%
oxygen (Table 2).
Moreover, these experiments revealed a minor decrease
in hyperplasia when inactivation of PHD2 was combined
with HIF-1α, whereas some aspects of the phenotype,
such as Type I cellular clearing and vascular expansion,
appeared to be exacerbated (Fig. 7B–D) or unchanged
(e.g. hypertrophy of Type I cells: 97 ± 2 vs. 102 ± 3
μm2 in Phd2f/f;THCre vs. Phd2f/f;Hif-1αf/f;THCre mice).
By contrast, combined inactivation of PHD2 with HIF-2α
resulted in atrophic CBs in which Type I cell TH
staining was almost absent and there was little or no
vascular development (Fig. 7B–D). In line with this,
in situ hybridization for Vegfa showed very high Vegfa
mRNA expression in CBs from Phd2f/f;Hif-1αf/f;THCre
mice and minimal Vegfa expression within the
carotids of Phd2f/f;Hif-2αf/f;THCre mice (Fig. 7E). These
results suggest that the phenotypes associated with
Figure 5. The effect of Type I cell-specific PHD2 inactivation
upon CB morphology and function
A and B, CB morphology and ventilation in n = 6 Phd2f/f;THCre mice
and Phd2f/f littermate controls. A, minute ventilation before, during
and after an acute hypoxic stimulus (10% oxygen with 3% carbon
dioxide – white bars). B, quantification of TH+ cell number and CB
volume (from TH immunostaining in C); Type I cell area (from
electron microscopy in D). C, representative images of TH (brown)
immunostaining with vascularization marked in red. Low
magnification images (upper) showing both the CB and the superior
cervical ganglion (SCG). High magnification images (lower) showing
the presence or absence of clearing in Type I cells (marked with black
arrowheads). D, electron microscopy imaging of cellular
ultrastructure and eccentric DCVs in Type I cells. Representative
DCVs and eccentric DCVs shown in inserts. Scale bars = 1 μm (low
power) and 100 nm (high power). Values shown are the mean ±
SEM; ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001.
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Table 2. Acute hypoxic ventilatory responses in mice with
inactivation of PHD2 in Type I cells combined with HIF-1α or
HIF-2α inactivation
Genotype Hypoxic ventilatory response
(mL min−1 g−1)
10% O2 10% O2/3% CO2
Phd2f/f –0.31 ± 0.42 4.33 ± 0.62
Phd2f/f;THCre –0.41 ± 0.43 5.17 ± 0.51
Phd2f/f;Hif-1αf/f;THCre 0.07 ± 0.68 4.07 ± 0.50
Phd2f/f;Hif-2αf/f;THCre –2.91 ± 0.50∗∗§§ 0.30 ± 0.62∗∗§§
ANOVA P value 0.0017 0.0023
Mean± SEM hypoxic ventilatory response values in age matched
male mice measured at 3 months of age. Values shown are
mean ± SEM changes in minute ventilation in response to the
indicated acute hypoxic stimulus; n = 3–11 mice per genotype.
Data were analysed by one-way ANOVA followed by Tukey’s
multiple comparison test. ∗∗P < 0.01, significantly different
from tamoxifen-treated Phd2f/f controls; §§P < 0.01, significantly
different from Phd2f/f;THCre mice.
pseudohypoxic PHD2 inactivation were dependent on
HIF-2α and are independent of, or exacerbated by,HIF-1α
inactivation.
Discussion
The CB undergoes rapid cellular proliferation and hyper-
trophy in response to sustained hypoxia. This response
is conserved across mammalian species and is associated
with important functional changes, including enhanced
ventilatory sensitivity to hypoxia (Edwards et al. 1971;
Arias-Stella & Valcarcel, 1973; Dhillon et al. 1984;
McGregor et al. 1984; Heath et al. 1985; Bishop et al.
2013). However, despite intensive study, the mechanisms
underlying these observations, including the interplay
between functional changes and different proliferating cell
populations, remain incompletely understood.
In the present study, we have used both lineage labelling
technology and lineage-restricted inactivation of specific
components of the HIF prolyl hydroxylase system to
investigate the cell type specific roles of that pathway
within the CB. Our study reveals the importance of this
systemwithin theType I cell lineagewith respect to driving
both proliferation and increased ventilatory sensitivity
to hypoxia. First, using lineage marking technology, we
demonstrate a large expansion of the Type I lineage in
CBs studied after a period of 28 days sustained hypoxia.
Second, we show that inactivation of the principal HIF
prolyl hydroxylase PHD2, specifically within the Type I
cells of the CB, is sufficient to drive multilineage hyper-
plasia and hypertrophy of the CB. Third, we show that
the integrity of HIF-2α, specifically within Type I cells, is
required both for this response and for the proliferative
changes that are observed upon exposure to sustained
hypoxia.Taken together, thesefindings suggest that,within
theCB, hypoxia acts on a population of Type I cells to drive
rapid expansion of that lineage, and that the integrity of
the PHD2–HIF-2α couple is critical to that process.
A number of previous studies have reported on the
origin of the cellular proliferation in hypoxic CBs.
Figure 6. The effect of Type I cell-specific PHD2 inactivation
upon CB vasculature
Representative images of CB tissues from Phd2f/f;THCre and Phd2f/f
littermate controls. A, endomucin immunostaining (green, CB edges
outlined in white). B, representative images of Vegfa mRNA (brown)
in situ hybridization in the CB; low power images (upper) show both
the CB and the superior cervical ganglion (SCG); high power images
(lower) of the CB. C, Vegfa mRNA (pink) in situ hybridization
combined with TH immunohistochemistry (brown).
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Although studies of the uptake of nucleoside analogues
have reported labelling of Type I cells in hypoxic CBs
(Wang&Bisgard, 2002;Wang et al. 2008), these studies do
not directly trace the origin of such cells and labelling may
reflect proliferation within another cell population that
has then differentiated into Type I cells. In this context,
evidence has been provided for the importance of glia-like
Type II cells, which act as a stem cell niche, and whose
rapid amplification and differentiation could account for
the expansion of multiple cell types, including Type I cells
(Pardal et al. 2007). By directly tracing and characterizing
the behaviour of lineage labelled Type I and Type II cells
in response to sustained hypoxia, we demonstrate that the
large majority of the Type I cell expansion that is observed
in hypoxia derives from the Type I lineage itself and not
via transdifferentiation from Type II cells. Although the
Type II lineage labelled population of cells did expand in
response to hypoxia, this expansion was smaller than that
of the Type I cells. Although we cannot exclude a low level
of transdifferentiation between Type I and Type II cells,
or vice versa, we only observed occasional cells whose
markers and morphology were compatible with this. Our
results therefore appear to be at odds with the hypothesis
that Type I cell expansion derives largely from a glia-like
stem cell niche (Pardal et al. 2007).
By contrast, when the manuscript of the present study
was under preparation, a further report was published
providingevidence for an immatureType I,TH-expressing
cell population that is capable of rapid division in
response to hypoxia (Sobrino et al. 2018). These cells were
distinguished by expression of the human natural killer
1 (HNK-1) membrane epitope and manifest differences
in their electrophysiological properties from mature Type
I cells, although they contained secretory vesicles, were
electrically excitable and expressed TH (Sobrino et al.
2018). Our findings are therefore consistent with this
report and suggest that, in response to sustained hypoxia,
this mode of Type I cell expansion (as opposed to trans-
differentiation fromglia-like Type II cells) is quantitatively
Figure 7. The effect of PHD2 inactivation in Type I cells
combined with HIF-1α or HIF-2α inactivation upon CB
morphology and function
A, minute ventilation before, during and after an acute hypoxic
stimulus (10% oxygen with 3% carbon dioxide – white bars) in
n = 3–11 Phd2f/f;THCre, Phd2f/f;Hif-1αf/f;THCre,
Phd2f/f;Hif-2αf/f;THCre mice and Phd2f/f littermate controls. B,
quantification of TH+ cell number and CB volume from
Phd2f/f;THCre (n = 6), Phd2f/f;Hif-1αf/f;THCre (n = 6) and
Phd2f/f;Hif-2αf/f;THCre mice (n = 3). C–E, representative images of
CBs from Phd2f/f;Hif-1αf/f;THCre and Phd2f/f;Hif-2αf/f;THCre mice. C,
TH (brown) immunostaining. D, endomucin (green) immunostaining
(CB edges in white). E, in situ hybridization for Vegfa mRNA (brown).
Data from Fig. 5A and B are reproduced for comparative purposes.
Values shown are the mean ± SEM; ∗∗P < 0.01, ∗∗∗P < 0.001,
∗∗∗∗P < 0.0001.
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the more important route, at least under the conditions of
our experiments.
Consistent with this, inactivation of PHD2 to create a
‘pseudohypoxic’ state specifically within Type I cells was
sufficient to create hyperplasia of the CBs that resembles,
but appears greater than (7-fold vs. 3- to 4-fold), that
observed following chronic hypoxic exposure (Laidler &
Kay, 1975; Dhillon et al. 1984; McGregor et al. 1984) or
in long-term dwellers at altitude (Edwards et al. 1971;
Arias-Stella & Valcarcel, 1973, 1976; Khan et al. 1988). By
contrast to the significantly enhanced hypoxic ventilatory
responses observed inmice following induced inactivation
of PHD2 or 7 days of sustained hypoxia exposure (Bishop
et al. 2013;Hodson et al. 2016), conditional inactivation of
PHD2 in Type I cells did not result in significant changes
in hypoxic ventilatory responses. Although this appears
to be inconsistent with the greatly increased Type I cell
number, it may reflect the long-term effects of HIF-2α
stabilization, in a process that is possibly analogous to
the hypoxic desensitization described in humans residing
at high altitude (Severinghaus et al. 1966; Lahiri et al.
1976).
The enlarged CBs associated with Type I cell restricted
PHD2 inactivation also manifest several features that are
reminiscent of human paraganglioma (Ashley & Evans,
1966;Robertson&Cooney, 1980;Kliewer et al. 1989; Jyung
et al. 2000; Van Den Berg et al., 2002; Wieneke & Smith,
2009). First, as well as expansion of the Type I population,
they manifest marked expansion of endothelial cells and
the vascular compartment. This indicates that signals
originating from Type I cells were capable of affecting
other lineages. Given that we did not observe trans-
differentiationofType I lineagemarked cells to endothelial
cells, themost probable possibility is that paracrine signals
from Type I cells drive expansion of the CB vasculature.
Although we have not formally demonstrated this, our
observation of very high levels of Vegfa mRNA in Type I
cells would be consistent with that hypothesis. Second, the
enlarged CBs frequently showed a ‘clear cell’ phenotype
by light microscopy, resembling the typical vacuolated
histology of Type I cells in human paraganglioma (Ashley
& Evans, 1966; Robertson & Cooney, 1980; Kliewer
et al. 1989; Wieneke & Smith, 2009). Ultrastructural
analysis revealed the presence of greatly enlarged vesicles
with eccentrically displaced cores suggesting that these
appearances arise, at least in part, as an extension of the
enlargement of dense core vesicular structure that was
evident after exposure to hypoxia. Thus, inactivation of
PHD2 in a TH positive Type I cell population mimicked
many of the effects of chronic exposure to hypoxia, with
some abnormalities being more marked in the genetic
condition perhaps because this ‘pseudohypoxic’ condition
cannot be compensated for by increases in oxygendelivery.
Interestingly, these results contrast with studies of VHL
inactivation in Type I cells, which led to an almost total
failure of CB development (Macias et al. 2014). It is
possible that the actions of VHL and PHD2 inactivation
are not equivalent because of non-overlapping actions on
systems other thanHIF. However, an intriguing possibility
is that the different outcomes arise from differences
in quantitative effects on HIF activation (i.e. PHD2
inactivation causes a different and potentially lower level
of HIF activation). Such a possibility would be consistent
with human genotype–phenotype correlations in VHL
disease where partial but not total loss of VHL function
on the regulation of HIF is associated with development
of pheochromocytoma (Kaelin, 2002, 2008).
It will require further studies to understand the precise
means by which inactivation of PHD2 leads to the
above phenotypes. The results of the present study in
conjunction with previous work, however, support a key
role for HIF-2α within the Type I cell lineage. Activation
of a stabilized form of HIF-2α by expression of THCre
has previously been shown to result in an expanded Type
I cell population (Macias et al. 2014). In the present
study, combined inactivation of HIF-2αwith PHD2 using
the same THCre transgene entirely prevented CB over-
growth and led to a vestigial organ in which the Type I
cells and associated vascular expansion were essentially
absent. Another report published when the manuscript
of the present study was under review demonstrated that
inactivation of HIF-2α under THCre also prevents CB
development (Macias et al. 2018). Moreover, in the pre-
sent study, we demonstrate that inducible inactivation of
HIF-2α in Type I cells in the adult was associated both
with much reduced proliferation of Type I cells and with
much reduced hypoxic ventilatory sensitivity.
These critical functions of HIF-2α within the CB are
consistent with the very high level of Hif-2α mRNA
within the organ demonstrated in both the present
study and other studies (Tian et al. 1998; Zhou et al.
2016; Gao et al. 2017). Furthermore, our current in
situ hybridization results are in accordance with single
cell transcriptomic studies with respect to indicating
tight restriction to the Type I cells (Zhou et al. 2016).
By contrast, Hif-1α mRNA is expressed at much lower
levels. In keeping with this, the effects of combined
HIF-1α inactivation on the CB phenotype associated
with PHD2 inactivation were more minor and not
always in the same direction. Although some reduction
in carotid overgrowth was observed in HIF-1α/PHD2
vs. PHD2 conditionally inactivated mice, the ‘clear cell’
phenotype appeared to be exaggerated in HIF-1α/PHD2
conditionally inactivated mice. Interestingly, somatic
gain-of-function mutations in HIF-2α but not HIF-1α
have been described in human paraganglioma (Toledo,
2017), including cases of Pacak–Zhuang syndrome, in
which affected individuals manifest paraganglioma, as
well as duodenal somatostatinoma and polycythaemia
(Zhuang et al. 2012; Pacak et al. 2013). Thus, both mouse
C© 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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andhumangenetics point to apredominant roleofHIF-2α
in CB hyperplasia.
Precisely how this relates to the organ’s oxygen sensing
function remains unclear. Interestingly, however, electron
microscopy studies revealed that inactivation of HIF-2α
prevented hypoxia-induced changes in bothDCVnumber
and appearance. This suggests that HIF-2α is critical
at some point on the pathway of hypoxia-inducible
vesicle release. Future studies aiming to investigate
whether HIF-2α regulates the acute oxygen sensitivity
of Type I cells to trigger neurosecretion will be of
interest.
Interestingly, it has been reported that blockade of
calcium-induced exocytosis impairs cell proliferation
within the CB (Platero-Luengo et al. 2014), raising
the possibility of a link between the roles of HIF-2α
inactivation in Type I cell function and proliferation.
At present, we cannot define precisely how increased
proliferation relates back to the enhanced ventilatory
responses to hypoxia, particularly because these effects
were not concordant between the 7–28 day hypoxic
exposures and long-term PHD2 inactivation. Nor can
we be certain that changes in ventilatory responses only
reflect actions of HIF-2α in the CB because the THCre
mouse strains that were used have the potential to
drive recombination in other catecholaminergic cells.
Nevertheless, assays of recombination using the lineage
tracer tdTomato indicated that recombination within
the CNS was very limited, with little or no signal
within the catecholaminergic neurons of the brain-
stem that have also been implicated in ventilatory
control.
Overall, our findings suggest that HIF-2α within the
Type I cell lineage of the CB plays a critical role both in its
oxygen sensing function and in its growth in response to
sustained hypoxia. The generation of aHIF-2α-dependent
paraganglioma-like phenotype following inactivation of
PHD2 provides a model for study of the pathogenesis
of these tumours and may provide insights into the role
of these pathways in promoting tumour growth in other
settings.
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Translational perspectives
The present study implicates specific components of theHIF hypoxia signalling pathway in both rapid
and long-term responses of the carotid body to hypoxia. Using lineage tracing technology and cell
type restricted recombination, the study reveals the cell-autonomous operation of these molecules
(PHD2/HIF-2α) within the Type I lineage, thus opening the way to examine the targets of the HIF
pathway operating within these cells. Apart from providing insights into the molecular physiology
of the carotid body and ventilatory control, the results of the study may inform on mechanisms
underlying cell proliferative responses to hypoxia that occur in disease, including cancers that express
high levels of HIF-2α. The development of agents that specifically target HIF-2α (Courtney et al.
2018) may enable treatment of paraganglioma-like tumours and our findings provide a model for
testing this hypothesis. Notably, these agents have been associated with occasional episodes of reduced
blood oxygen saturation in patients who received them for the treatment of kidney cancer, consistent
with an action on the physiology of oxygen delivery to the blood.
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